Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigmund Silber

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2016
Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial ProgramCarlo Di Mario, Patrick W Serruys, Sigmund Silber, et al.
Circulation|September 30, 2009
Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesionsSigmund Silber, Antonio Colombo, Adrian P Banning, et al.
BMC Health Services Research|June 19, 2014
Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine dataMajed Aljutaili, Christian Becker, Sabine Witt, et al.
Heart (British Cardiac Society)|July 24, 2012
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reportingPascal Vranckx, Vasim Farooq, Scot Garg, et al.
The American Journal of Cardiology|September 5, 2002
Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowingsRainer Hoffmann, Gunhild Herrmann, Sigmund Silber, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trialJoshua P Loh, Pieter R Stella, Giuseppe Sangiorgi, et al.
Herz|June 26, 2003
[4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002]Benny Levenson, Alexander Albrecht, Stefan Göhring, et al.
Circulation. Cardiovascular Interventions|June 7, 2015
Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trialJavaid Iqbal, Patrick W Serruys, Sigmund Silber, et al.
The Journal of Invasive Cardiology|December 9, 2003
Clinical outcome following combination of cutting balloon angioplasty and coronary beta-radiation for in-stent restenosis: a report from the RENO registryChristian Roguelov, Eric Eeckhout, Edoardo De Benedetti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
'Fused-Gold' vs. 'Bare' stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP StudyStephen Fort, Ran Kornowski, Sigmund Silber, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2016
Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial ProgramCarlo Di Mario, Patrick W Serruys, Sigmund Silber, et al.
Circulation|September 30, 2009
Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesionsSigmund Silber, Antonio Colombo, Adrian P Banning, et al.
BMC Health Services Research|June 19, 2014
Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine dataMajed Aljutaili, Christian Becker, Sabine Witt, et al.
Heart (British Cardiac Society)|July 24, 2012
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reportingPascal Vranckx, Vasim Farooq, Scot Garg, et al.
The American Journal of Cardiology|September 5, 2002
Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowingsRainer Hoffmann, Gunhild Herrmann, Sigmund Silber, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trialJoshua P Loh, Pieter R Stella, Giuseppe Sangiorgi, et al.
Herz|June 26, 2003
[4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002]Benny Levenson, Alexander Albrecht, Stefan Göhring, et al.
Circulation. Cardiovascular Interventions|June 7, 2015
Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trialJavaid Iqbal, Patrick W Serruys, Sigmund Silber, et al.
The Journal of Invasive Cardiology|December 9, 2003
Clinical outcome following combination of cutting balloon angioplasty and coronary beta-radiation for in-stent restenosis: a report from the RENO registryChristian Roguelov, Eric Eeckhout, Edoardo De Benedetti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
'Fused-Gold' vs. 'Bare' stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP StudyStephen Fort, Ran Kornowski, Sigmund Silber, et al.
Pageof 20